Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124228) titled 'Efficacy and Safety of Utidelone Combined with Anlotinib as Second-Line Therapy for Advanced Non-Specific Soft Tissue Sarcoma: A Multicenter, Single-Arm, Phase II Clinical Study' on May 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shandong First Medical University Affiliated Tumor Hospital
Condition:
Soft tissue sarcoma, not otherwise specified
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-05-09
Target Sample Size: Experimental group:63;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=32159...